What We Do
We are dedicated to
working with the
healthcare industry to
prevent medication errors.
Med-ERRS uses Failure Mode & Effects Analysis (FMEA)
medication names, packages and labels. We also employ techniques and
methodologies recommended by the US Food and Drug Administration, as
well as other regulatory authorities.
Med-ERRS tests proposed trademarks in the
pre-marketing phase for new drug products to identify and prevent potential look-alike and
sound-alike confusion with existing products. In addition, Med-ERRS evaluates the design
of drug packaging and labels to maximize safety during use. Our
consultative services are
provided to pharmaceutical, biotechnology and technology companies in need of expert
review, evaluation and direction on the safe use of their products. Besides pre-marketing
services, Med-ERRS also works with pharmaceutical companies to provide
post-marketing services that analyze potential and actual medication errors.